Telik (TELK)

Add to Watchlists Create an Alert
1.32 -0.04  -3.30%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Telik R&D Expense Quarterly:

0.736M for Dec. 31, 2012
View Full Chart

Telik R&D Expense Quarterly Chart

    Telik Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.786M
    Dec. 31, 2012 0.736M
    Sept. 30, 2012 0.867M
    June 30, 2012 0.932M
    March 31, 2012 0.989M
    Dec. 31, 2011 1.102M
    Sept. 30, 2011 1.305M
    June 30, 2011 1.465M
    March 31, 2011 1.694M
    Dec. 31, 2010 2.838M
    Sept. 30, 2010 2.569M
    June 30, 2010 2.808M
    March 31, 2010 2.825M
    Dec. 31, 2009 2.295M
    Sept. 30, 2009 3.416M
    June 30, 2009 3.022M
    March 31, 2009 3.99M
    Dec. 31, 2008 2.701M
    Sept. 30, 2008 4.82M
    June 30, 2008 8.236M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    TELK R&D Expense Quarterly Benchmarks

    Companies
    Acura Pharmaceuticals 2.026M
    Horizon Pharma 4.739M
    Sagent Pharmaceuticals 4.261M

    TELK R&D Expense Quarterly Rankings

    Overall 83rd percentile
    1331 of 8006
    Sector 41st percentile
    404 of 686 in Healthcare
    Industry 22nd percentile
    53 of 68 in Drug Manufacturers - Specialty & Generic

    TELK R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.7360M Dec 2012
    Maximum 8.236M Jun 2008
    Average 2.470M